iMD to expand Medical Diagnostics operations

As a result of its recent acquisition announced yesterday of Optimum Mobile Imaging LLC ("OMI"),  iMD is actively seeking to dramatically expand its overall Medical Diagnostics operations. Currently operating mainly in the Phoenix area, iMD will expand OMI's services throughout the state.  We believe we can gain traction in this growing Medical Diagnostics market within several additional parts of the country including FL, UT, CA and TX. With the financial resources to attract qualified marketing representatives , iMD hopes to have OMI operating in all these states within the next 12 months.  This initial expansion should serve to multiply revenues exponentially.  Our analysis shows that Independent Diagnostic Testing Facility (IDTF's) such as the ones described herein can generate annual revenues of $20 million as we increase our penetration into each state.

Saeb Jannoun stated, "We are very pleased to be moving quickly to fully integrate OMI and to grow our diagnostics revenues.  We are fully committed to increase shareholder value as we grown our Medical Diagnostics group, and by seeking additional acquisition candidates that will be accretive to earnings."

Source:

iMD Companies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U.S. cancer detection severely disrupted during first year of COVID-19, shows incomplete recovery in second year